Comparing rheumatoid arthritis treatments in Saudi Arabia
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study compares different drugs used to treat rheumatoid arthritis in Saudi Arabia. If you have rheumatoid arthritis and have been treated for at least a year, this study may help doctors learn which medicines work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with rheumatoid arthritis.
- You have been followed by a doctor for at least 12 months.
- You have had at least 3 doctor visits for your condition.
- You know the exact date you started your current rheumatoid arthritis medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how two types of rheumatoid arthritis (RA) medications affect patients. It aims to compare anti-TNF drugs with other RA drugs to see if one type is better.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This Phase 3 study compares two ways to treat active rheumatoid arthritis: a TNF-blocking biologic versus a targeted pill treatment. It may help people who are not doing well on (or cannot tolerate) certain biologic therapies to find a better, more practical option.
This trial tests a step-by-step plan for treating rheumatoid arthritis when current medicines aren’t controlling the disease. It compares how well a targeted approach works by adjusting treatment for people who need a TNF inhibitor.
This study looks at people with adult rheumatoid arthritis to see how long biological medicines and “JAK inhibitors” keep helping. It uses routine clinic follow-up records to understand how well treatment persists over time and how outcomes change.
Hear when a new Rheumatoid Arthritis RA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.